About Acuity Spatial Genomics
Acuity Spatial Genomics is a company based in Watertown (United States) founded in 2020 was acquired by Bruker in March 2021. Acuity Spatial Genomics operates in a competitive market with competitors including Biomodal, Aligned Bio, Singular Bio, YouScript and Nooma Bio, among others.
- Headquarter Watertown, United States
- SectorsHealthcare
- Email••••••••
- Website acuityspatialgenomics.com
- Acquired by Bruker (Mar 2021)
Investors in Acuity Spatial Genomics
Acuity Spatial Genomics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Bruker.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Diversified research instrument systems are manufactured and supplied. | 1960 | bruker.com | United States |
Investor details for Acuity Spatial Genomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Acuity Spatial Genomics
21 people are tracked at Acuity Spatial Genomics (6 in leadership, 15 in team).
| Name | Role | Group |
|---|---|---|
David King | Associate Director | Leadership |
Mark R. Munch | CEO | Leadership |
Jude Dunne | Vice President, New Product Development, Assays And Assay Sysyems | Leadership |
Huy Nguyen | Chief Technology Officer & Co-founder | Leadership |
Suvarna Gandlur | Vice President, Product Management & Marketing | Leadership |
Shyamtanu Chattoraj | Co-founder And Chief Scientific Officer (cso) | Leadership |
Siobhan Kernag | Staff Scientist | Team |
Lei Zhu | Staff Scientist | Team |
Johnson Huynh | Research Associate | Team |
Brian Smart | Principal Scientist | Team |
Pedro Quelhas | Staff Software Engineer - Analytics | Team |
Eric L. | Senior Staff System Engineer | Team |
Chad Sanada | Senior Staff Scientist | Team |
Justin Houser | Scientist | Team |
Natalya Kotova | Senior Research Associate | Team |
Aric Rininger | Senior Research Associate | Team |
Deanne Cuda | Sr. Research Associate - Workflow | Team |
Serdar Tulu | Staff Scientist | Team |
Ryan Mack | Mechanical Engineer | Team |
Kenny Chung | Senior System Engineer | Team |
1 more people are available in the full profile.
Complete people profiles for Acuity Spatial Genomics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Acuity Spatial Genomics
2 dated milestones of Acuity Spatial Genomics across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Acuity Spatial Genomics is founded.
- Exit Acquired by Bruker.
Competitors of Acuity Spatial Genomics
Acuity Spatial Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biomodal, Aligned Bio, Singular Bio, YouScript and Nooma Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biomodal.com | 2012 | Cambridge, United Kingdom | $164.1M | – | Developer of DNA sequencing tools and technology for research and diagnostics | |
| alignedbio.com | 2019 | Lund, Sweden | $908,526 | – | Nanowire-based sensors and alignment technologies are provided for molecular detection. | |
| singularbio.com | 2012 | San Francisco, United States | $6.6M | – | Tools for single molecule detection are developed by Singular Bio. | |
| youscript.com | 2000 | Seattle, United States | – | 14 | Clinical decision support software for drug interactions is developed. | |
| nooma.bio | 2020 | Santa Cruz, United States | – | 14 | Dual-nanopore technology is developed for genome-wide structural and epigenetic variations. | |
| hawkbiosystems.com | 2015 | Derio, Spain | – | – | Clinical assays are developed for quantifying novel biomarkers in samples. | |
| annogen.bio | 2019 | Amsterdam, Netherlands | – | – | Genetic variations are screened via a specialized genomic platform. | |
| dnatechnologies.com | 1993 | Los Angeles, United States | – | – | Anti-counterfeiting and brand protection solutions are delivered via DNA-laced markers. | |
| geospiza.com | 1997 | Seattle, United States | $4.8M | – | Enterprise software systems for genetic analysis workflows are developed. |
Detailed competitors of Acuity Spatial Genomics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Acuity Spatial Genomics
Complete news archive for Acuity Spatial Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Acuity Spatial Genomics
10 companies that operate in the same segment as Acuity Spatial Genomics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Acuity Spatial Genomics
Acuity Spatial Genomics was founded in 2020.
Acuity Spatial Genomics is headquartered in Watertown, United States.
Acuity Spatial Genomics was founded in 2020 and is based in Watertown, United States. Operations focus on the genomics sector, where a 3D platform is developed for multi-omic analyses. The OligoFISSEQ technology is employed to visualize 3D chromosome structures, genomic analyses, and chromatin architecture, including TADs, loops, and enhancer-promoter complexes, along with their topologies and conformations.
Acuity Spatial Genomics's top competitors include Biomodal, Aligned Bio and Singular Bio.
Acuity Spatial Genomics has 1 investor. Key investors include Bruker.
Yes. Acuity Spatial Genomics was acquired by Bruker in March 2021.